Panacea Biotec

Rediff.com » News » Panacea Biotec

News for Panacea Biotec

News
Business

First-ever phase-3 trial for dengue vaccine begins in India

The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated the first-ever phase three clinical trial for developing a dengue vaccine in India, the Union Health Ministry said on......

India's First Dengue Vaccine Likely To Be Ready By 2026

Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024. Kindly......

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in......

India to produce 850mn Sputnik doses annually: RDIF

The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......

Russia reaches out to Kerala for Sputnik V plant

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......

WHO gives India five more mths to upgrade standard

The World Health Organization has given five more months to the Drugs Controller General of India to upgrade its performance to international standards. The extension of the current deadline of......

WHO refuses vaccine approval

The World Health Organization has not approved any new vaccine from India this year as the Indian regulatory system, which gives manufacturing licences for domestic vaccines, has failed to meet its......

Five Indians among 40 influential pharma faces

London-based SPG Media, publishers of the annual World Pharmaceutical Frontiers survey, has included five Indians among the top 40 influential people in the global pharmaceutical industry in 2008.......

India's biotech export touches $1.2 billion

India's export revenue from biotechnology grew by 47 percent to reach 1.2 billion dollars in the financial year ended March 2007, a survey said.According to a survey conducted by the Association on......

Panacea eyes Latin America

Panacea Biotec is planning to launch its organ transplantation drugs to Latin American and South East Asian markets. The company is also looking for enlarging the scope of organ transplantation......

Rediff News

Panacea Biotec

News for Panacea Biotec

First-ever phase-3 trial for dengue vaccine begins in India

India's First Dengue Vaccine Likely To Be Ready By 2026

Sputnik V production begins in India; 100mn jabs to be manufactured per year

India to produce 850mn Sputnik doses annually: RDIF

Russia reaches out to Kerala for Sputnik V plant

WHO gives India five more mths to upgrade standard

WHO refuses vaccine approval

Five Indians among 40 influential pharma faces

India's biotech export touches $1.2 billion

Panacea eyes Latin America

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS